About this speaker:

Dr. Jeffrey Hunt is Professor and Deputy Division Director in the Division of Child and Adolescent Psychiatry and Program Director for the Child and Adolescent Psychiatry Fellowship and the Triple Board Program at the Alpert Medical School of Brown University. He is also Director of Inpatient and Intensive Services at Bradley Hospital in Rhode Island. Dr. Hunt has been co-investigator on numerous NIMH funded studies relating to mood disorders including the Course and Outcome of Bipolar Youth Study. He holds leadership roles within AACAP, ABPN, and ACGME. He is an AACAP- Harvard Macy Scholar and is a faculty member in the Harvard Macy health care educator courses. Dr. Hunt received his MD from the Medical College of Wisconsin and general and child and adolescent psychiatry training at the Medical College of Pennsylvania at the Eastern Pennsylvania Psychiatric Institute (now Drexel University College of Medicine).

Disclosure Statements:

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt Health System, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Jeffrey I. Hunt, MD, reports having received research funding form NIMH, publishing royalties from Whiley Publishing, during the past 12 months. He will discuss generic SSRIs and atypical medications used for treating irritability in youth in this presentation. Review of his materials found no conflicts of interest.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, M.D., Briana Riemer, M.D., Sunil Khushalani, M.D., Faith Dickerson, Ph.D., Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Stacey Garnett, RN, MSN, Paul Daugherty, RN, MBA, Heather Billings, RN, and Jennifer Tornabene.